Advertisement

Topics

Shire Canada Release: ONIVYDE (Irinotecan Liposome For Injection) Has Received Approval In Canada For The Treatment Of Metastatic Adenocarcinoma Of The Pancreas In The Post-Gemcitabine Setting(1)

20:00 EDT 10 Aug 2017 | BioSpace

  Life Sciences Jobs   ...

Original Article: Shire Canada Release: ONIVYDE (Irinotecan Liposome For Injection) Has Received Approval In Canada For The Treatment Of Metastatic Adenocarcinoma Of The Pancreas In The Post-Gemcitabine Setting(1)

NEXT ARTICLE

More From BioPortfolio on "Shire Canada Release: ONIVYDE (Irinotecan Liposome For Injection) Has Received Approval In Canada For The Treatment Of Metastatic Adenocarcinoma Of The Pancreas In The Post-Gemcitabine Setting(1)"

Quick Search
Advertisement